Atormac
Home  -  About us  -  Editorial board  -  Search  -  Ahead of print  -  Current issue  -  Archives  -  Instructions  -  Subscribe  -  Contacts  -  Advertise - Login 
 
 
     

 Table of Contents  
CASE REPORT - CYST AND TUMORS
Year : 2012  |  Volume : 2  |  Issue : 2  |  Page : 178-181

Locally advanced salivary duct carcinoma of the parotid gland


1 Dr. BRA-IRCH, Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India
2 Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

Date of Web Publication25-Sep-2012

Correspondence Address:
Rajni Yadav
Department of Pathology, All India Institute of Medical Sciences, New Delhi - 110 029
India
Login to access the Email id


DOI: 10.4103/2231-0746.101354

PMID: 23482905

Rights and Permissions
  Abstract 

Due to the low incidence of salivary duct carcinoma (SDC), there is limited data in regard to the biologic behavior of this tumor, histopathological characteristics and its management. There is diversity in the management of parotid SDC. Various authors manage it with radical parotidectomy with or without neck dissection; others add adjuvant radiotherapy with radical surgery. The objective of the study is to see the biological behavior and management of the three patients with locally advanced SDC and review with the literature.

Keywords: Adjuvant, carcinoma, ductal, radiotherapy, salivary gland neoplasms


How to cite this article:
Kallianpur A, Yadav R, Shukla NK, Deo S, Muduly DK. Locally advanced salivary duct carcinoma of the parotid gland. Ann Maxillofac Surg 2012;2:178-81

How to cite this URL:
Kallianpur A, Yadav R, Shukla NK, Deo S, Muduly DK. Locally advanced salivary duct carcinoma of the parotid gland. Ann Maxillofac Surg [serial online] 2012 [cited 2019 Jul 21];2:178-81. Available from: http://www.amsjournal.com/text.asp?2012/2/2/178/101354


  Introduction Top


Salivary duct carcinoma (SDC) is a rare malignant epithelial tumor and is characterized histologically by multiple neoplastic epithelial nests similar to the ductal carcinoma of the breast. Although first described by Kleinsassar et al. in 1968, SDC was not formally recognized in the World Health Organization classification of salivary gland tumors until 1991. [1],[2] Salivary duct carcinoma is a high-grade malignant tumor exhibiting aggressive growth with early regional and distant metastasis. SDC mainly affects the older male patients. [1],[2] This study reports a case series of three patients of SDC of the parotid gland including one with a sarcomatoid variant, managed by multimodality therapy.


  Case Reports Top


Case 1

A 35-year old female had presented to the department with a painless lump over the left preauricular region since last 7 months. She also complained of trismus and difficulty in closing the left eyelid. Physical examination showed a 6 × 5cm hard mass in the left preauricular region fixed to the underlying tissues and overlying skin. There were palpable upper cervical lymph nodes. Computed Tomography revealed a large necrotic mass involving the left parotid, infiltrating the masseter muscle and the overlying skin [Figure 1]. Fine needle aspiration cytology was suggestive of carcinoma. A total left radical parotidectomy with enbloc excision of the overlying skin, left modified neck dissection, and reconstruction of the defect with pectoralis major myocutaneous flap (PMMC) were carried out under general anaesthesia. The intra-operative finding was a hard mass involving both the superficial and deep lobe of parotid gland and infiltrating the masseter muscle and the mandibular condyle periosteum. There were multiple cervical lymph nodes at all levels of the left side of neck. Histopathology was suggestive of salivary duct carcinoma involving the parotid gland. Two out of seven nodes dissected were positive histopathologically for SDC. Patient received 60 grays of external beam radiotherapy [EBRT] in thirty fractions. The patient is on regular follow-up since last 8 years and is disease free with no evidence of recurrence or distant metastasis.
Figure 1: Represents the computed tomography of a patient with salivary duct carcinoma which shows a mass arising from the left parotid gland infiltrating the deep lobe and the masseter muscle

Click here to view


Case 2

A 50-year old male had presented to the department with left facial nerve palsy and a lump over the preauricular region since 8 months. Computed Tomography revealed a large mass involving the superficial and deep lobe of left parotid gland. A total left radical parotidectomy with enbloc excision of the overlying skin, left modified neck dissection, and reconstruction of the defect with PMMC were carried out under general anaesthesia. The intra-operative finding was a hard mass of size 5×4 cm involving both the lobes of parotid gland and infiltrating the overlying skin. Histopathology was suggestive of SDC with metastases to 12 of the thirteen nodes dissected [Figure 2]. Immunohistochemistry was positive for cytokeratin and Her2 neu. Patient received 60 grays of adjuvant EBRT to the loco-regional site. He is on regular follow-up and is disease free since last 6 months.
Figure 2: Represents the histopathology suggestive of salivary duct carcinoma

Click here to view


Case 3

A 42-year old female had presented to the department with a lump over the right preauricular region since 3 months. Physical examination showed a 5×4 cm hard lump in the right preauricular region. She had no cervical lymphadenopathy nor any clinical signs of facial nerve palsy. Computed Tomography revealed a lump involving the superficial lobe of right parotid gland with no adjacent structures being involved. She underwent facial nerve preserving radical parotidectomy [Figure 3] with supraomohyoid neck dissection. Histopathology was suggestive of SDC with no nodal metastases. Histopathologically, there was a striking resemblance to ductal carcinoma of the breast with central comedo necrosis and some areas of sarcomatoid morphology. Immunohistochemistry was positive for cytokeratin and negative for SMA, desmin and myogenin in both the areas [Figure 4]. Patient received 60 grays of EBRT and is on regular follow-up. She had no signs of recurrence since seven months of surgery.
Figure 3: Represents the intraoperative finding showing the mass arising from the superficial lobe of parotid gland

Click here to view
Figure 4: a] Tumor cells with spindle shape arranged in illdefined fascicles and solid sheet(x100), b] Tumor nuclei showing marked pleomorphism in sarcomatoid area, c] Cytokeratin positive in sarcomatoid area, d] Apocrine snouts in tumor cells towards luminal side, e] Cytokeratin positive in the comedo area, f] Desmin negative, g] Myogenin negative, h] Smooth muscle actin negative, i] Tumor cells showing Her 2 neu positivity

Click here to view



  Discussion Top


Salivary duct carcinoma represents a rare and aggressive tumor with an estimated incidence of 1-3% of all malignant salivary gland tumors. [2],[3] SDC commonly arises from the parotid gland and clinically presents as a rapidly growing mass infiltrating the facial nerve. Most treated patients with SDC present with early loco-regional recurrence with high propensity for distant metastases to the lung, bone and liver. [2] Seventy percent of the patients with SDC die of their disease within 3 years of diagnosis due to widespread metastases. [2]

Histopathologically SDC bears a striking similarity to ductal carcinoma of the breast and is composed of intra ductal and invasive components. Similar to the breast carcinoma, the intra ductal component may appear as a cribriform, papillary, or solid growth pattern, often with comedo like central necrosis. The invasive carcinoma consists of irregular glands and cords of cells that frequently elicit a prominent desmoplastic reaction. Salivary duct carcinoma can occur de novo or as the malignant component of carcinoma ex pleomorphic adenoma. [4] Most pathologists stress on the presence of flat sheets of tumor cells with cribriform patterns as characteristic feature of SDC. [4]

Delgado et al. based on the degree of intra ductal or infiltrative component have classified SDC into 3 subtypes: 1) Predominantly intra ductal, where 90% of the tumor is intra ductal 2) Predominantly infiltrative, when less than 20% of the tumor is intra ductal or 3) Infiltrative, when the tumor is entirely infiltrative. [5] The significance of this classification is not known but it has been seen that the predominantly infiltrative tumor has dismal prognosis. [5]

Several variants of SDC such as sarcomatoid variant, low grade or mucin rich SDC have been described. [5],[6],[7] Literature reviews on the sarcomatous variant of SDC have been reported in only sixteen patients till date. Sarcomatoid SDC is characterized histologically by a biphasic neoplasm with carcinomatous and sarcomatoid elements. Nagao et al. in his review of patients with sarcomatous SDC, reported 25% patients dying of disease within 2 years of completion of treatment. [6] He concluded that sarcomatoid SDC is a highly aggressive tumor, similar to conventional SDC.

Due to the rarity of this malignancy, no consistent therapeutic concept and protocol exists for this tumor entity. Majority treat patients with SDC with a radical surgical approach and adjuvant external radiotherapy [Table 1] [7],[8],[9],[10],[11],[12],[13] whereas others recommend adjuvant therapy based on the pathological stage, grade, margin and perineural invasion. [7] Recurrence was seen in all the patients reported in literature with parotid SDC who have undergone parotidectomy and did not undergo lymph nodal neck dissection. [7] In the present series, all the three patients have been treated with a radical approach that includes radical parotidectomy, neck dissection and adjuvant radiotherapy. In this case series, one of the three locally advanced SDC patients has survived disease free even 96 months after completion of treatment. There by we stress the fact that oncological cure in patients with SDC can still be achieved with the radical surgical approach and adjuvant radiotherapy.
Table 1: Salivary duct carcinoma of the parotid gland reported in the English-language literature

Click here to view



  Conclusion Top


Salivary duct carcinoma is characterized by aggressive growth, a high incidence of early lymph node metastasis, and frequent local recurrences after surgical excision. Combined modality that includes radical surgery with neck dissection and adjuvant radiotherapy may result in the oncological cure of the disease.

 
  References Top

1.Kleinsasser O, Klein HJ, Hubner G. [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1968;192:100-5.  Back to cited text no. 1
    
2.Seifert G, Sobin LH, Thackray AC. Histological typing of salivary gland tumors. WHO International Histological Classification of Tumors. 2 nd Ed. New York: Springer-Verlag Publishers; 1991.  Back to cited text no. 2
    
3.Gal R, Strauss M, Zohar Y, Kessler E. Salivary duct carcinoma of the parotid gland. Cytologic and histopathologic study. Acta Cytol 1985;29:454-56.  Back to cited text no. 3
    
4.Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases. Hum Pathol 2001;32:596-604.  Back to cited text no. 4
    
5.Delgado R, Vuitch F, Albores-Saavedra J. Salivary duct carcinoma. Cancer 1993;72:1503-12.  Back to cited text no. 5
    
6.Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, et al. Sarcomatoid variant of salivary duct carcinoma: Clinicopathologic and immunohistochemical study of eight cases with review of the literature. Am J Clin Pathol 2004;122:222-31.  Back to cited text no. 6
    
7.Jamal AM, Sun ZJ, Chen XM, Zhao YF. Salivary duct carcinoma of the parotid gland: Case report and review of the literature. J Oral Maxillofac Surg 2008;66:1708-13.  Back to cited text no. 7
    
8.Butterworth DM, Jones AW, Kotecha B. Salivary duct carcinoma: Report of a case and review of the literature. Virchows Arch A Pathol Anat Histopathol 1992;420:371-4.  Back to cited text no. 8
    
9.Minamiguchi S, Iwasa Y, Shoji K, Higuchi K, Watanabe C, Haga H, et al. Salivary duct carcinoma: A clinicopathologic study of three cases with a review of the literature. Pathol Int 1996;46:614-22.  Back to cited text no. 9
    
10.Kruslin B, Scukanec-Spoljar M, Separoviæ V, Manojloviæ S, Jankoviæ D, Daniloviæ Z. Salivary duct carcinoma metastasizing to the small bowel. Tumori 1996;82:502-4.  Back to cited text no. 10
    
11.Ikeda K, Yoshida F, Suzuki H, Oshima T, Hirano K, Takasaka T. A case report of salivary duct carcinoma. Tohoku J Exp Med 1997;183:233-8.  Back to cited text no. 11
    
12.Madrigal B, García J, De Vicente JC. Salivary duct carcinoma: An unusual case of long-term evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:597-602.  Back to cited text no. 12
    
13.Bhalla R, Parker DC, Tadros TS. Salivary duct carcinoma metastatic to inguinal lymph node: A case report of salivary duct carcinoma with distant metastasis diagnosed by fine-needle aspiration. Diagn Cytopathol 2006;34:41-4.  Back to cited text no. 13
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1]



 

Top
 
 
Search
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
  Introduction
  Case Reports
  Discussion
  Conclusion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed4294    
    Printed82    
    Emailed0    
    PDF Downloaded399    
    Comments [Add]    

Recommend this journal